Female obesity does not impact live birth rate after frozen-thawed blastocyst transfer.


Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
28 04 2020
Historique:
received: 23 09 2019
revised: 03 12 2019
pubmed: 15 3 2020
medline: 28 4 2021
entrez: 15 3 2020
Statut: ppublish

Résumé

Does female obesity affect live birth rate after frozen-thawed blastocyst transfer? Live birth rate was not statistically different between obese and normal weight patients after frozen-thawed blastocyst transfer (FBT). Obesity is a major health problem across the world, especially in women of reproductive age. It impacts both spontaneous fertility and clinical outcomes after assisted reproductive technology. However, the respective impact of female obesity on oocyte quality and endometrial receptivity remains unclear. While several studies showed that live birth rate was decreased in obese women after fresh embryo transfer in IVF cycle, only two studies have evaluated the effects of female body mass index (BMI) on pregnancy outcomes after frozen-thawed blastocyst transfer (FBT), reporting conflicting data. This retrospective case control study was conducted in all consecutive frozen-thawed autologous blastocyst transfer (FBT) cycles conducted between 2012 and 2017 in a single university-based centre. A total of 1415 FBT cycles performed in normal weight women (BMI = 18.5-24.9 kg/m2) and 252 FBT cycles performed in obese women (BMI ≥ 30 kg/m2) were included in the analysis. Endometrial preparation was standard and based on hormonal replacement therapy. One or two blastocysts were transferred according to couple's history and embryo quality. Female and male age, smoking status, basal AMH level and type of infertility were comparable in obese and normal weight groups. Concerning FBT cycles, the duration of hormonal treatment, the stage and number of embryos (84% single blastocyst transfer and 16% double blastocysts transfer) used for transfer were comparable between both groups. Mean endometrium thickness was significantly higher in obese than in normal weight group (8.7 ± 1.8 vs 8.1 ± 1.6 mm, P < 0.0001). Concerning FBT cycle outcomes, implantation rate, clinical pregnancy rate and live birth rate were comparable in obese and in normal weight groups. Odds ratio (OR) demonstrated no association between live birth rate after FBT and female BMI (OR = 0.92, CI 0.61-1.38, P = 0.68). Anthropometric parameters such as hip to waist ratio were not used. Polycystic ovarian syndrome status was not included in the analysis. Our study showed that live birth rate after frozen-thawed blastocyst transfer was not statistically different in obese and in normal-weight women. Although this needs confirmation, this suggests that the impairment of uterine receptivity observed in obese women after fresh embryo transfer might be associated with ovarian stimulation and its hormonal perturbations rather than with oocyte/embryo quality. No external funding was received. There are no competing interests. N/A.

Identifiants

pubmed: 32170315
pii: 5804222
doi: 10.1093/humrep/deaa010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

859-865

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Auteurs

E Prost (E)

Department of Biology and Reproductive Medicine, University Hospital of Nantes, Nantes, France.

A Reignier (A)

Department of Biology and Reproductive Medicine, University Hospital of Nantes, Nantes, France.
Faculty of Medicine, University of Nantes, Nantes, France.
Center for Research in Transplantation and Immunology UMR 1064, INSERM, University of Nantes, Nantes, France.

F Leperlier (F)

Department of Biology and Reproductive Medicine, University Hospital of Nantes, Nantes, France.

P Caillet (P)

Department of Public Health, University Hospital of Nantes, Nantes, France.

P Barrière (P)

Department of Biology and Reproductive Medicine, University Hospital of Nantes, Nantes, France.
Faculty of Medicine, University of Nantes, Nantes, France.
Center for Research in Transplantation and Immunology UMR 1064, INSERM, University of Nantes, Nantes, France.

T Fréour (T)

Department of Biology and Reproductive Medicine, University Hospital of Nantes, Nantes, France.
Faculty of Medicine, University of Nantes, Nantes, France.
Center for Research in Transplantation and Immunology UMR 1064, INSERM, University of Nantes, Nantes, France.

T Lefebvre (T)

Department of Biology and Reproductive Medicine, University Hospital of Nantes, Nantes, France.
Faculty of Medicine, University of Nantes, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH